Form 4 for LFCR LIFECORE BIOMEDICAL, INC. DE
Accepted 2026-03-02 00:00:00 ET · period of report 2026-03-02 · accession 0002062209-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | 2026-03-02 | LFCR | Salus Thomas D. | Chief Legal, Administration | A - Grant | — | +30.0K | 271.0K | +12% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | A | A | 30,000 | — | 270,978 | D | — | — | (F1) The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. (F2) Restricted Stock Units will vest on the 3rd anniversary of the grant date. |